0001209191-18-021643.txt : 20180326
0001209191-18-021643.hdr.sgml : 20180326
20180326171159
ACCESSION NUMBER: 0001209191-18-021643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180323
FILED AS OF DATE: 20180326
DATE AS OF CHANGE: 20180326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEAVER GREGORY L
CENTRAL INDEX KEY: 0001251779
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 18713459
MAIL ADDRESS:
STREET 1: 185 BERRY STREET
STREET 2: SUITE 6504
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001035354
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 841368850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (858) 909-0749
MAIL ADDRESS:
STREET 1: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Sevion Therapeutics, Inc.
DATE OF NAME CHANGE: 20140930
FORMER COMPANY:
FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991006
FORMER COMPANY:
FORMER CONFORMED NAME: NAVA LEISURE USA INC
DATE OF NAME CHANGE: 19970310
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-23
0
0001035354
Eloxx Pharmaceuticals, Inc.
ELOX
0001251779
WEAVER GREGORY L
C/O ELOXX PHARMACEUTICALS, INC.
950 WINTER STREET, 4TH FLOOR NORTH
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
Common Stock
2018-03-23
4
P
0
4500
8.56
A
4500
D
/s/ Gregory Weaver
2018-03-26